Professional Documents
Culture Documents
net/publication/239322409
CITATION READS
1 1,596
1 author:
John Yeast
Saint Luke's Health System (KS, USA)
54 PUBLICATIONS 1,450 CITATIONS
SEE PROFILE
All content following this page was uploaded by John Yeast on 06 May 2015.
The online version of this article, along with updated information and services, is
located on the World Wide Web at:
http://neoreviews.aappublications.org/cgi/content/full/neoreviews;7/6/e300
NeoReviews is the official journal of the American Academy of Pediatrics. A monthly publication,
it has been published continuously since 2000. NeoReviews is owned, published, and trademarked
by the American Academy of Pediatrics, 141 Northwest Point Boulevard, Elk Grove Village,
Illinois, 60007. Copyright © 2006 by the American Academy of Pediatrics. All rights reserved.
Online ISSN: 1526-9906.
Introduction
Polyhydramnios, sometimes referred to as hydramnios, is a relatively uncommon compli-
cation affecting pregnancy that refers to the presence of an excessive amount of amniotic
fluid relative to gestational age. Onset may be gradual or sudden, based on the cause.
Gradual onset may be largely asymptomatic. In this situation, the diagnosis is suspected
when fundal height exceeds that expected for gestational age. In contrast, sudden onset of
polyhydramnios often is symptomatic, characterized by contractions and significant ab-
dominal discomfort. Polyhydramnios has potential serious consequences, primarily related
to the cause, but also due to the increased risk of adverse pregnancy outcome, such as
preterm labor (PTL) or preterm premature rupture of the membranes (PPROM).
Diagnosis
The clinical suspicion of abnormally large fundal size remains critical to the diagnosis of
polyhydramnios. Serial measurements of uterine height at the time of prenatal visits can
stimulate the clinician to consider possible causes of abnormal fundal size. Subsequently,
obstetric ultrasonography can confirm the presence of abnormally increased amniotic fluid
volume and allow a thorough study of the fetus for possible anatomic causes.
Over the past 25 years, a number of investigators have created models to standardize the
measurement of amniotic fluid volume. In some instances, they have compared and
contrasted formulas for measuring amniotic fluid volume with precise, objective invasive
methods, such as dye dilution studies. Others have compared subjective assessment of
amniotic fluid volume with various formula models. Subjective measurements, however,
do not allow comparisons of values between different observers.
An experienced sonographer can assess the amniotic fluid volume subjectively and have
*Professor and Vice Chairman, Department of Obstetrics and Gynecology, University of Missouri-Kansas City School of
Medicine; Director of Medical Affairs, Saint Luke’s Hospital of Kansas City, Kansas City, Mo.
a high index of suspicion that the amount is increased. In term. These estimates are based on ultrasonography-
addition, a sonographer can use one of the objective derived measures of fetal bladder volume changes in
methods to diagnose polyhydramnios. However, when pregnancy. Lung fluid production has been estimated to
intraobserver results are compared, there is a poor corre- be 150 to 170 mL/d, with most of the fluid excreted into
lation unless the fluid volume is very abnormal. the amniotic fluid compartment. Lung fluid production
The amniotic fluid index (AFI) has been the most appears to be critical to maintaining growth and devel-
studied objective measure of amniotic fluid volume. The opment of the alveoli. In addition, some studies suggest
sonographer divides the uterus into four quadrants and that the excess amount of fluid produced creates a pres-
measures the greatest vertical depth of fluid without fetal sure differential in the terminal bronchioles that further
parts present in each quadrant. The sum of these mea- expands the developing alveolar buds.
surements is the AFI. This method is not used prior to Fluid leaves the amniotic cavity in the second half of
20 weeks’ gestation. The upper limit of normal for the pregnancy largely via two routes. First, fetal swallowing
AFI is 20 cm, with values of 20 to 24 cm considered normally accounts for the vast amount of fluid leaving
borderline. the amniotic compartment. It is estimated that the late-
Normal AFI values generally are well supported in term fetus swallows about 500 to 1,000 mL/d. The fetal
most studies. However, diagnosing polyhydramnios by gastrointestinal tract absorbs fluid and solutes and re-
AFI compared with dye studies showed a sensitivity of turns them to the maternal compartment via the pla-
only 30% and a positive predictive value of 57%. As centa. Less well understood is the egress of fluid via the
expected, specificity was good at 98%. Other methods of intramembranous process. It is well documented in fetal
objectively measuring amniotic fluid volume, such as lambs and other animal models that a moderate amount
measuring the greatest two diameters of the largest of fluid can be absorbed via the placental surface. Inter-
pocket of amniotic fluid noted (⬎50 cm being the crite- estingly, in fetal sheep models, occlusion of fetal swallow-
rion for polyhydramnios) or measuring the single deep- ing results in a marked increase of intramembranous fluid
est pocket of fluid noted (⬎8 cm indicating polyhydram- flow. One estimate of normal flow via the transmembra-
nios) also have poor sensitivity, at 38% and 29%, nous route is approximately 300 to 400 mL/d.
respectively. Regulation of normal amniotic fluid volume, that is,
Despite the poor correlation of objective measure- the balance of fluid production and removal, is poorly
ments of fluid volume with precise dye-dilution studies, a understood. Animal models that artificially increase fluid
subjective suspicion of polyhydramnios should be fol- production or restrict fluid removal by one mechanism
lowed by ultrasonography using one of the objective show that alternate mechanisms can readily adapt and
measures of amniotic fluid noted. Serial studies subse- adjust their role in homeostasis of fluid volume. How-
quently can be employed to evaluate for changes in fluid ever, the “sensors” that control such mechanisms are
volume. unknown. Possibly, fluid volume, osmolality, and elec-
trolyte concentrations all contribute to amniotic fluid
Causes homeostasis in the healthy fetus.
The production of amniotic fluid and the maintenance of From a clinical perspective, polyhydramnios results
normal amniotic fluid volume are critical to the develop- from an overproduction of amniotic fluid or an interrup-
ment of a normal fetus. (See the article by Gilbert in this tion in the removal of fluid from the amniotic cavity.
issue of NeoReviews.) Production of amniotic fluid varies Causes can be subdivided further into maternal or fetal
by gestational age. Early in the pregnancy, fluid primarily origin (Table 1). The primary maternal cause of polyhy-
results from transmembranous secretion via the amnion dramnios is diabetes mellitus, which may contribute up
and the body surface of the embryo. By the early second to 25% of the cases recognized. However, such cases of
trimester, the fetus begins to produce urine, and fluid polyhydramnios usually are in the mild-to-moderate
also is secreted from the fetal lungs, egressing into the range and seldom are associated with significant morbid-
amniotic cavity. By 20 to 22 weeks’ gestation, the fetal ity. The precise cause in maternal diabetes seems to be
skin surfaces keratinize and no longer are a source of the increase in fetal urine production, probably related to
amniotic fluid. Thus, most of the fluid in the latter half of increased osmotic gradients in fetal blood flow from the
gestation comes from the fetal kidneys and, to a lesser placenta due to hyperglycemia.
extent, fetal lungs. Fetal causes of polyhydramnios can be divided primar-
Fetal urine production is estimated at 2 to 5 mL/h ily into two general categories: neurologic inhibition of
around 22 to 24 weeks’ gestation and almost 50 mL/h at the fetal swallowing mechanism and mechanical obstruc-
fetal jeopardy. Reduction in maternal activity and in- amniotomy can result in placental abruption. The fetus
creased bedrest may be prudent, although neither has should be monitored continuously at all times during
been shown conclusively to change outcome. In some labor and delivery.
instances, polyhydramnios resolves spontaneously.
Maternal symptoms are the most common reason for
therapeutic intervention. If the patient becomes symp-
tomatic, either with uterine irritability, respiratory com- Suggested Reading
Cardwell MS. Polyhydramnios: a review. Obstet Gynecol Surv. 1987;
promise, or discomfort, treatment may be necessary to
42:612– 617
prolong the pregnancy. Based on gestational age, two Carlson D, Platt L, Medearis A, Horenstein J. Quantifiable poly-
options are available: amnioreduction or the use of pros- hydramnios: diagnosis and management. Obstet Gynecol 1990;
taglandin inhibitors to attempt a medical reduction of 75:989 –993
fluid production. Chauhan SP, Magann EF, Morrison JC, Whitworth NS, Hendrix
NW, Devoe LD. Ultrasonographic assessment of amniotic fluid
Amnioreduction should be performed by personnel
does not reflect actual amniotic fluid volume. Am J Obstet
familiar with the procedure. Using ultrasonography Gynecol. 1997;177:291–296
guidance, a large-bore needle is placed in the amniotic Dashe JS, McIntire DD, Ramus RM, Santos-Ramos R, Twickler
cavity, and fluid is removed via a suction pump. The goal DM. Hydramnios: anomaly prevalence and sonographic detec-
is to remove fluid slowly, reducing fluid volume to a tion. Obstet Gynecol. 2002;100:134 –139
Elliott JP, Sawyer AT, Radin TG, Strong RE. Large-volume thera-
near-normal AFI of less than 25 cm. Some patients
peutic amniocentesis in the treatment of hydramnios. Obstet
require mild sedation, analgesics, or tocolytics for the Gynecol. 1994;84:1025–1027
procedure, although most tolerate the amnioreduction Golan A, Wolman I, Sagi J, Yovel I, David MP. Persistence of
without incident. The amniotic fluid volume should be polyhydramnios and preterm delivery. Gynecol Obstet Invest.
evaluated frequently (at least twice weekly) and the pro- 1994;37:18 –20
Harding R, Bocking AD, Sigger JN, Wickham PJ. Composition and
cedure repeated when symptoms recur or volumes begin
volume of fluid swallowed by sheep. Q J Exp Physiol. 1984;69:
to increase significantly. Some patients may require serial 487– 495
procedures to prolong pregnancy. Careful informed con- Hill L, Breckle R, Thomas ML, Fries JK. Polyhydramnios: ultra-
sent must be obtained because the procedure may pre- sonically detected prevalence and neonatal outcome. Obstet
cipitate PTL or PPROM. Also, the risk/benefit balance Gynecol. 1987;69:21–25
Kirshon B, Mari G, Moise KJ Jr. Indomethacin therapy in the
versus gestational age must be considered carefully.
treatment of symptomatic polyhydramnios. Obstet Gynecol.
Some data suggest that prostaglandin inhibitors, such 1990;75:202–205
as indomethacin or ibuprofen, may reduce fetal urine Magann EF, Chauhan SP, Barrilleaux PS, Whitworth NS, Martin
production. Although no controlled, randomized stud- JN. Amniotic fluid index and single deepest pocket: weak indi-
ies have compared methods of therapy, medical therapy cators of abnormal amniotic fluid volumes. Obstet Gynecol.
2000;96:737–740
may be considered, especially when polyhydramnios de-
Modena AB, Fieni S. Amniotic fluid dynamics. Acta Biomed Ateneo
velops at early gestational ages. Due to the concern over Parmense. 2004;75(suppl):11–13
fetal ductus arteriosus closure with prostaglandin treat- Moise KJ Jr. Polyhydramnios. Clin Obstet Gynecol. 1997;40:
ment, therapy should be conducted only in perinatal 266 –279
centers that have the ability to follow fetal ductal blood Ott WJ. Reevaluation of the relationship between amniotic fluid
volume and perinatal outcome. Am J Obstet Gynecol. 2005;192:
flow. In addition, it would seem prudent not to use such
1803–1809
therapy beyond 32 weeks gestational age. Phelan JP, Park YW, Ahn MO, Rutherford SE. Polyhydramnios and
Treatment of significant polyhydramnios prior to perinatal outcome. J Perinatol. 1990;10:347–350
term may include corticosteroid therapy to enhance fetal Piantelli G, Bedocchi L, Cavicchioni O, et al. Amnioreduction for
lung maturity. Antepartum surveillance with ultrasonog- treatment of severe polyhydramnios. Acta Biomed Ateneo Par-
mense. 2004;75:56 –58
raphy and cardiotocography should be employed prior to
Pritchard JA. Fetal swallowing and amniotic fluid volume. Obstet
delivery. The goal of all therapy is to assure fetal and Gynecol. 1966;28:606 – 610
maternal well-being and allow the fetus to reach matu- Quinlan RW, Amelia CC, Martin M. Hydramnios: ultrasound
rity. In some cases, however, delivery prior to fetal ma- diagnosis and its impact on perinatal management and preg-
turity may result or be indicated. The method of delivery nancy outcome. Am J Obstet Gynecol. 1983;145:306 –311
Smith C, Plambeck RD, Rayburn WF, Albaugh KJ. Relation of mild
depends on fetal well-being and standard obstetric indi-
idiopathic polyhydramnios to perinatal outcome. Obstet Gy-
cations. Increased amniotic fluid volume does increase necol. 1992;79:387–389
the chance of fetal malposition or funic (cord) presenta- Underwod MA, Gilbert WM, Sherman MP. Amniotic fluid: not just
tion. Sudden uterine decompression with PPROM or fetal urine anymore. J Perinatol. 2005;25:341–348
NeoReviews Quiz
4. Polyhydramnios is a complication of pregnancy whose estimated incidence is up to 1.6% of pregnancies in
a low-risk population. Of the following, the most accurate statement regarding polyhydramnios is that:
A. Approximately 10% of cases have no identifiable cause.
B. Cases that have a gradual onset are generally asymptomatic.
C. Early diagnosis has been proven to improve perinatal outcome.
D. Measurement of the amniotic fluid index is best performed before 20 weeks’ gestation.
E. Most cases are moderate-to-severe and associated with sequelae.
5. Polyhydramnios results from an overproduction of amniotic fluid or an interruption in its removal from the
amniotic cavity. The causes of polyhydramnios can be of maternal or fetal origin. Of the following, the
most common fetal cause of polyhydramnios is:
A. Decreased absorption of amniotic fluid due to gastrointestinal atresia.
B. Decreased fetal swallowing from neuromuscular disorder.
C. Excessive transudation of fluid from an abdominal wall defect.
D. Increased fetal lung fluid secretion associated with gestational diabetes.
E. Increased fetal urine output from hydrops associated with anemia.
6. The treatment of polyhydramnios during pregnancy depends on several factors, including the degree of
excess amniotic fluid, maternal symptoms, and gestational age of the fetus. Of the following, the most
common obstetric intervention for polyhydramnios is:
A. Amnioreduction.
B. Expectant observation.
C. Reduction in maternal activity.
D. Treatment with diuretics.
E. Treatment with prostaglandin inhibitors.